Tumor News and Research

RSS

Researchers discover that DNA fragments destroy melanoma cells

Researchers at Boston University School of Medicine have discovered that small DNA fragments or oligonucleotides that resemble the telomere (chromosome end), also called T-oligos, can cause human melanoma cells to undergo extensive apoptosis (cell death), while surviving melanoma cells become more differentiated and therefore less aggressive.

1 Sep 2004

Women over 70 are safe to not have radiation treatment after heaving a lumpectomy

Two new studies reported in The New England Journal of Medicine suggest that older women with breast cancer are safe to not have radiation treatment after heaving a lumpectomy.

1 Sep 2004

Mammography screening reduces risk of distant tumor recurrence

Women who have breast cancer detected by mammography screening have a reduced risk of distant tumor recurrence than women with breast cancer detected outside of screening, according to a study in the September 1 issue of JAMA.

1 Sep 2004

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA today announced that they have signed a definitive merger agreement under which MGI PHARMA will acquire all outstanding equity of Aesgen for $32 million in cash.

1 Sep 2004

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

A well known anti-cancer agent in certain vegetables has just had its reputation enhanced. The compound, in broccoli and other cruciferous vegetables, has been found to be effective in disrupting late stages of cell growth in breast cancer.

1 Sep 2004

Patent issued for non invasive treatment of kidney and ureteric stone technology

Issued on August 24, 2004, the patent covers the new technology of Twinheads(R) which uses two or more shock wave sources in the extracorporeal shock wave lithotripsy; the non invasive treatment of kidney and ureteric stones. Further patents are pending.

1 Sep 2004

Study is the first comprehensive risk analysis to examine both the risk of death from breast cancer and other causes following diagnosis

Women who are diagnosed with breast cancer at a young age, or at an advanced stage at any age, are more likely to die from the disease than from all other causes of death combined, according to a new study by scientists at the National Cancer Institute.

1 Sep 2004

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

“There are many types and subtypes of lymphoma, some of which are easy to detect, but many that are very difficult to identify,” says Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute at Temple and one of the study’s principal investigators.

1 Sep 2004

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

An enzyme found in nearly all animal and human cells acts as a natural brake to prevent potentially deadly runaway inflammation, UCSF scientists have discovered.

30 Aug 2004

Cinical trial to evaluate breakthrough breast cancer treatment

Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.

30 Aug 2004

New guidelines today to diagnose and treat acromegaly

The American Association of Clinical Endocrinologists (AACE) released new guidelines today to diagnose and treat acromegaly, a rare and debilitating endocrine disorder. The guidelines are published in the May/June 2004 issue of AACE's peer-reviewed journal Endocrine Practice.

29 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Researchers using light to control genes and better understand the role of certain genes in embryonic development

As our understanding of biology increases, the tools of research become almost as important as the researchers wielding them. Currently, one of the major obstacles to research is actually getting inside of cells and tissue to see what is going on as it happens.

25 Aug 2004

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Virginia Commonwealth University researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients and in those with cirrhosis, which may help scientists predict a person’s risk of developing primary liver cancer.

25 Aug 2004

Scientists have uncovered a key driver behind the progression of prostate cancer

Scientists at Fred Hutchinson Cancer Research Center have uncovered a key driver behind the progression of prostate cancer, a discovery that the researchers believe could spawn new treatments to prevent the cancer's spread and extend survival.

23 Aug 2004

Powerful new cancer-fighting property of Herceptin

For many patients with advanced breast cancer, the cancer drug Herceptin (trastuzumab) has offered new hope when traditional cancer drugs failed to work, shrinking tumors and sending some patients into remission.

23 Aug 2004

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

Two upcoming studies by scientists at the National Cancer Institute (NCI), provide further evidence that exposure to simian virus 40 (SV40) is not associated with cancer in humans.

23 Aug 2004

African-American women are less likely to be treated with breast reconstruction after mastectomy than women of other races

According to a new study published August 23, 2004 in the online edition of CANCER, a peer-reviewed journal of the American Cancer Society, African-American women had significantly lower immediate breast reconstruction rates compared to Caucasian, Asian, and Hispanic women. The abstract of this article will be freely accessible via the CANCER Newsroom.

23 Aug 2004

Dual-action compound shows promise in killing prostate cancer cells

Ohio State University researchers are working on developing a multi-purpose cancer drug that might one day scale back the number of medications some cancer patients need to take.

22 Aug 2004

Test for identifying which cases of prostate cancer will become life threatening

Karin Drotschmann, Ph.D., a researcher at Wake Forest University Baptist Medical Center, has won the “New Investigator Award” from the Department of Defense, Prostate Cancer Research Program, for her work to develop a test for identifying which cases of prostate cancer will become life threatening.

20 Aug 2004

Tumor News and Research

Researchers discover that DNA fragments destroy melanoma cells

Women over 70 are safe to not have radiation treatment after heaving a lumpectomy

Mammography screening reduces risk of distant tumor recurrence

MGI PHARMA acquires Aesgen for $32 million

Broccoli, cauliflower and cabbage effective in disrupting late stages of cell growth in breast cancer

Patent issued for non invasive treatment of kidney and ureteric stone technology

Study is the first comprehensive risk analysis to examine both the risk of death from breast cancer and other causes following diagnosis

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

Common enzyme acts as a natural brake to prevent potentially deadly runaway inflammation

Cinical trial to evaluate breakthrough breast cancer treatment

New guidelines today to diagnose and treat acromegaly

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Researchers using light to control genes and better understand the role of certain genes in embryonic development

Researchers have identified multiple changes in the gene-expression patterns of cells involved with tumor progression in liver cancer patients

Scientists have uncovered a key driver behind the progression of prostate cancer

Powerful new cancer-fighting property of Herceptin

Exposure to simian virus 40 (SV40) is not associated with cancer in humans

African-American women are less likely to be treated with breast reconstruction after mastectomy than women of other races

Dual-action compound shows promise in killing prostate cancer cells

Test for identifying which cases of prostate cancer will become life threatening

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News